Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Pharmacoeconomics|August 3, 2019
Value Assessment and Quantitative Benefit-Risk Modelling of Biosimilar Infliximab for Crohn's DiseaseHeather Catt, Keith Bodger, Jamie J Kirkham, et al.
Gastrointestinal Endoscopy|August 13, 2011
All-cause mortality after first ERCP in England: clinically guided analysis of hospital episode statistics with linkage to registry of deathKeith Bodger, Katherine Bowering, Sanchoy Sarkar, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|September 27, 2012
The effect of high quality assurance measures in bowel cancer screening on patient satisfaction of colonoscopySanchoy Sarkar, Varinder Athwal, Richard P Sturgess, et al.
Pharmacoeconomics|October 21, 2005
Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux diseaseDyfrig A Hughes, Keith Bodger, Peter Bytzer, et al.
Inflammatory Bowel Diseases|December 31, 2013
Endoscopic balloon dilatation of Crohn's disease strictures: results from a large United kingdom seriesMahesh Bhalme, Sanchoy Sarkar, Simon Lal, et al.
European Journal of Gastroenterology & Hepatology|November 2, 2012
A multicentre study to determine the incidence, demographics, aetiology and outcomes of 6-day emergency readmission following day-case endoscopySanchoy Sarkar, Joe Geraghty, Andrew R Moore, et al.
Health and Quality of Life Outcomes|January 13, 2023
Implementing electronic patient reported outcomes in inflammatory bowel disease: patient participation, score reliability and validityDaniel Deutscher, Clara Weil, Gabriel Chodick, et al.
Pageof 4